Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.
| Period | Ended | Value | Kind | Source trail |
|---|---|---|---|---|
| FY 2025 | 2025-06-30 | A$42,000 | reported | |
| FY 2024 | 2024-06-30 | A$2,308,000 | reported | |
| FY 2023 | 2023-06-30 | A$0 | reported | |
| FY 2022 | 2022-06-30 | A$0 | reported | |
| FY 2021 | 2021-06-30 | A$15,183,000 | reported | |
| FY 2018 | 2018-06-30 | A$119,000 | reported | |
| FY 2017 | 2017-06-30 | A$249,000 | reported | |
| FY 2016 | 2016-06-30 | A$406,000 | reported |
Kazia Therapeutics Ltd · CIK 1075880 · Engraved from SEC EDGAR
Kazia Therapeutics Ltd is the 298th largest of the 553 covered companies the SEC files under this code, by market cap. SIC 2834
Latest filing Nov 19, 2026
The ifrs-full concepts with the most facts on file for this company.
Peers are the covered companies filed under the same SIC code, then under codes that share its first three digits or its first two, nearest in market cap first. Figures are each company’s latest fiscal year as filed; market cap is at its latest price.
| Fiscal year | Dividends | Buybacks | Total | Per share | Shares | Shares · yoy | of free cash flow |
|---|---|---|---|---|---|---|---|
| FY2025 | A$0.00 | — | A$0.00 | — | 809.42M sh | +143.2% | — |
| FY2024 | A$0.00 | — | A$0.00 | — | 332.85M sh | +46.0% | — |
| FY2023 | A$0.00 | — | A$0.00 | — | 228.03M sh | +64.3% | — |
| FY2019 | A$0.00 | — | A$0.00 | — | 62.17M sh | +28.4% | — |
| FY2018 | A$0.00 | — | A$0.00 | — | 48.41M sh | — | — |
No reported open-market purchases or sales in the last 12 months.